As an endogenous metabolite of astrocyte KP, KYNA exerts anti-inflammatory and antioxidant functions by binding to aryl hydrocarbon receptor (AHR) and is widely used in treating neurodegenerative diseases [10,11,12]. This evidence concerns the gene AHR and neurodegenerative disease.